Ditchcarbon
  • Contact
  1. Organizations
  2. Medincell
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated a month ago

Medincell Sustainability Profile

Company website

Medincell, a pioneering biopharmaceutical company headquartered in France, focuses on the development of innovative long-acting injectable therapies. Founded in 2000, the company has made significant strides in the industry, particularly in the fields of mental health and chronic diseases. Medincell's proprietary technology platform, which enables the sustained release of active pharmaceutical ingredients, sets it apart from competitors. With a strong presence in Europe and expanding operations globally, Medincell is committed to addressing unmet medical needs through its core products, including its lead candidate for the treatment of schizophrenia. The company has garnered recognition for its unique approach to drug delivery, positioning itself as a leader in the biopharmaceutical sector. Medincell continues to advance its mission of improving patient outcomes through innovative therapeutic solutions.

DitchCarbon Score

How does Medincell's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

38

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Medincell's score of 38 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

57%

Let us know if this data was useful to you

Medincell's reported carbon emissions

In 2024, Medincell reported approximately 7,070,000 kg CO2e in Scope 3 emissions, with significant contributions from purchased goods and services (about 5,053,000 kg CO2e), business travel (about 767,000 kg CO2e), and capital goods (about 707,000 kg CO2e). The previous year, 2023, saw similar Scope 3 emissions, totalling around 6,000,000 kg CO2e, with the largest sources being purchased goods and services (about 5,120,000 kg CO2e) and business travel (about 248,000 kg CO2e). In 2022, Medincell disclosed a total of 666,074,000 kg CO2e in emissions, although the specific scopes were not detailed. For Scope 1 and 2 emissions, the company reported 9,820 kg CO2e in 2022, with no emissions recorded for Scope 1. Despite these figures, Medincell has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to the Science Based Targets initiative (SBTi). The company’s climate strategy appears to be in its early stages, focusing on transparency in emissions reporting without established reduction goals. Overall, Medincell's emissions data reflects a significant reliance on Scope 3 emissions, highlighting the need for a comprehensive approach to climate commitments and reduction strategies in the future.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
-
-
-
-
-
-
Scope 2
8,380
0,000
0,000
0,000
-
-
Scope 3
-
-
-
-
0,000,000
0,000,000

How Carbon Intensive is Medincell's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Medincell's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Medincell's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Medincell is in FR, which has a very low grid carbon intensity relative to other regions.

Medincell's Scope 3 Categories Breakdown

Medincell's Scope 3 emissions, which increased by 10% last year and increased by approximately 10% since 2023, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Purchased Goods and Services" being the largest emissions source at 73% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
73%
Business Travel
11%
Capital Goods
10%
Employee Commuting
4%
Upstream Leased Assets
1%
Waste Generated in Operations
<1%

Medincell's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Medincell has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Medincell's Emissions with Industry Peers

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 18 hours ago

Luye Pharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Pharmathen

GR
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy